Bricks, clicks, and quick commerce: Prashant Tandon breaks down Tata 1mg’s integrated healthcare playbook

On a humid May afternoon, seated in his Gurugram residence, Prashant Tandon speaks with the calm assurance of someone who has spent over a decade navigating both regulatory mazes and the challenges of one of the most complex sectors—healthcare.

As the co-founder and CEO of Tata 1mg, Tandon has been the steady hand guiding the company’s transformation from a medicine information app to one of India’s most prominent digital health platforms. This has seen him emerge as one of the most authoritative voices in healthcare.

Since its acquisition by the Tata Group in 2021, 1mg has evolved from an e-pharmacy into a full-stack outpatient healthcare business, offering diagnostics, teleconsultations, private label offerings, rapid medicine delivery, and most recently, offline retail and institutional healthcare.